GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹465 Cr | ₹387 Cr | ₹354 Cr | ₹355 Cr | ₹491 Cr |
What is the latest Contingent Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹465 Cr |
| Mar2024 | ₹387 Cr |
| Mar2023 | ₹354 Cr |
| Mar2022 | ₹355 Cr |
| Mar2021 | ₹491 Cr |
How is Contingent Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹465 Cr | 20.04 | |
| Mar2024 | ₹387 Cr | 9.46 | |
| Mar2023 | ₹354 Cr | -0.26 | |
| Mar2022 | ₹355 Cr | -27.75 | |
| Mar2021 | ₹491 Cr | - | |
Compare Contingent Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹40,145.3 Cr | -3.4% | -8.6% | 7.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,037.0 Cr | -1.3% | -3.9% | -5.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,795.0 Cr | -2.3% | 0.9% | 12.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,332.0 Cr | 0.3% | 3.9% | 19.2% | Stock Analytics | |
| CIPLA | ₹116,933.0 Cr | -4.2% | -3.1% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,350.2 Cr | -3.2% | -4.5% | -11.8% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -3.4% |
-8.6% |
7.6% |
| SENSEX | -1.7% |
-1.4% |
7% |
You may also like the below Video Courses